Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development arena
Coronavirus disease, COVID-19, has touched every country globally except five countries
(North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective …
(North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective …
Perspectives on RNA vaccine candidates for COVID-19
P Borah, PK Deb, NA Al-Shar'i… - Frontiers in Molecular …, 2021 - frontiersin.org
With the current outbreak caused by SARS-CoV-2, vaccination is acclaimed as a public
health care priority. Rapid genetic sequencing of SARS-CoV-2 has triggered the scientific …
health care priority. Rapid genetic sequencing of SARS-CoV-2 has triggered the scientific …
[HTML][HTML] mRNA vaccines for COVID-19: what, why and how
JW Park, PNP Lagniton, Y Liu… - International journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The Coronavirus disease-19 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …
DNA vaccines against COVID-19: Perspectives and challenges
MM Silveira, GMSG Moreira, M Mendonça - Life sciences, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus known
as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is associated …
as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is associated …
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
ABSTRACT Introduction: Coronavirus outbreak 2019 (COVID-19) has affected all the
corners of the globe and created chaos to human life. In order to put some control on the …
corners of the globe and created chaos to human life. In order to put some control on the …
COVID-19 vaccines: an overview of different platforms
D Kudlay, A Svistunov - Bioengineering, 2022 - mdpi.com
Vaccination is one of the key strategies to stop the COVID-19 pandemic. This review aims to
evaluate the current state of vaccine development and to determine the issues that merit …
evaluate the current state of vaccine development and to determine the issues that merit …
Advances in COVID-19 mRNA vaccine development
E Fang, X Liu, M Li, Z Zhang, L Song, B Zhu… - Signal transduction and …, 2022 - nature.com
To date, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …
syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 …
[HTML][HTML] COVID-19 vaccines
D Ndwandwe, CS Wiysonge - Current opinion in immunology, 2021 - Elsevier
Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
The importance of RNA-based vaccines in the fight against COVID-19: an overview
BAS Machado, KVS Hodel, LMS Fonseca… - Vaccines, 2021 - mdpi.com
In recent years, vaccine development using ribonucleic acid (RNA) has become the most
promising and studied approach to produce safe and effective new vaccines, not only for …
promising and studied approach to produce safe and effective new vaccines, not only for …
mRNA vaccines against SARS-CoV-2: Advantages and caveats
M Echaide, L Chocarro de Erauso… - International Journal of …, 2023 - mdpi.com
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …